{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T04:26:13Z","timestamp":1743567973740,"version":"3.40.3"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T00:00:00Z","timestamp":1736035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T00:00:00Z","timestamp":1736035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s10549-024-07602-5","type":"journal-article","created":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T10:50:51Z","timestamp":1736074251000},"page":"635-644","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Frequency of somatic and germline variants of predisposition genes in young Chinese women with breast cancer"],"prefix":"10.1007","volume":"210","author":[{"given":"Yuchun","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qindong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yali","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weifeng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yibin","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangmeng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,5]]},"reference":[{"key":"7602_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249","journal-title":"CA Cancer J Clin"},{"key":"7602_CR2","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/cac2.12207","volume":"41","author":"S Lei","year":"2021","unstructured":"Lei S, Zheng R, Zhang S et al (2021) Global patterns of breast cancer incidence and mortality: a population-based cancer registry data analysis from 2000 to 2020. Cancer Commun (Lond) 41:1183\u20131194","journal-title":"Cancer Commun (Lond)"},{"key":"7602_CR3","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/jamaoncol.2017.0424","volume":"3","author":"FJ Couch","year":"2017","unstructured":"Couch FJ, Shimelis H, Hu C et al (2017) Associations between cancer predisposition testing panel genes and breast cancer. JAMA Oncol 3:1190\u20131196","journal-title":"JAMA Oncol"},{"key":"7602_CR4","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/carcin\/bgx010","volume":"38","author":"MR Han","year":"2017","unstructured":"Han MR, Zheng W, Cai Q et al (2017) Evaluating genetic variants associated with breast cancer risk in high and moderate-penetrance genes in Asians. Carcinogenesis 38:511\u2013518","journal-title":"Carcinogenesis"},{"key":"7602_CR5","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1158\/1078-0432.CCR-11-2283","volume":"18","author":"MH Tan","year":"2012","unstructured":"Tan MH, Mester JL, Ngeow J, Rybicki LA, Orloff MS, Eng C (2012) Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res 18:400\u2013407","journal-title":"Clin Cancer Res"},{"key":"7602_CR6","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.gde.2010.02.009","volume":"20","author":"A Hollestelle","year":"2010","unstructured":"Hollestelle A, Wasielewski M, Martens JW, Schutte M (2010) Discovering moderate-risk breast cancer susceptibility genes. Curr Opin Genet Dev 20:268\u2013276","journal-title":"Curr Opin Genet Dev"},{"key":"7602_CR7","doi-asserted-by":"publisher","first-page":"13019","DOI":"10.1002\/cam4.5976","volume":"12","author":"M Ni","year":"2023","unstructured":"Ni M, Wang F, Yang A et al (2023) What is the appropriate genetic testing criteria for breast cancer in the Chinese population?-Analysis of genetic and clinical features from a single cancer center database. Cancer Med 12:13019\u201313030","journal-title":"Cancer Med"},{"key":"7602_CR8","doi-asserted-by":"publisher","first-page":"6113","DOI":"10.1158\/1078-0432.CCR-16-3227","volume":"23","author":"J Sun","year":"2017","unstructured":"Sun J, Meng H, Yao L et al (2017) Germline mutations in cancer susceptibility genes in a large series of unselected breast cancer patients. Clin Cancer Res 23:6113\u20136119","journal-title":"Clin Cancer Res"},{"key":"7602_CR9","first-page":"1126","volume":"23","author":"L Yang","year":"2022","unstructured":"Yang L, Xie F, Liu C et al (2022) Germline variants in 32 cancer-related genes among 700 Chinese breast cancer patients by next-generation sequencing: a clinic-based. Observational Study Int J Mol Sci 23:1126","journal-title":"Observational Study Int J Mol Sci"},{"key":"7602_CR10","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1200\/JCO.2007.14.2471","volume":"26","author":"CK Anders","year":"2008","unstructured":"Anders CK, Hsu DS, Broadwater G et al (2008) Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 26:3324\u20133330","journal-title":"J Clin Oncol"},{"key":"7602_CR11","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1245\/s10434-006-9345-9","volume":"14","author":"JK Kim","year":"2007","unstructured":"Kim JK, Kwak BS, Lee JS et al (2007) Do very young Korean breast cancer patients have worse outcomes? Ann Surg Oncol 14:3385\u20133391","journal-title":"Ann Surg Oncol"},{"key":"7602_CR12","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1200\/JCO.2015.65.8013","volume":"34","author":"AH Partridge","year":"2016","unstructured":"Partridge AH, Hughes ME, Warner ET et al (2016) Subtype-dependent relationship between young age at diagnosis and breast cancer survival. J Clin Oncol 34:3308\u20133314","journal-title":"J Clin Oncol"},{"key":"7602_CR13","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s10549-018-4950-4","volume":"172","author":"Z Liu","year":"2018","unstructured":"Liu Z, Sahli Z, Wang Y, Wolff AC, Cope LM, Umbricht CB (2018) Young age at diagnosis is associated with worse prognosis in the Luminal a breast cancer subtype: a retrospective institutional cohort study. Breast Cancer Res Treat 172:689\u2013702","journal-title":"Breast Cancer Res Treat"},{"key":"7602_CR14","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.3390\/ijms25052490","volume":"25","author":"F Canino","year":"2024","unstructured":"Canino F, Tornincasa A, Bettelli S et al (2024) Real-world data and clinical implications of next-generation sequencing (NGS)-based analysis in metastatic breast cancer patients. Int J Mol Sci 25:2490","journal-title":"Int J Mol Sci"},{"key":"7602_CR15","doi-asserted-by":"publisher","first-page":"246","DOI":"10.6004\/jnccn.2023.0051","volume":"21","author":"MB Daly","year":"2023","unstructured":"Daly MB, Pal T, Maxwell KN et al (2023) NCCN guidelines(R) insights: genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2024. J Natl Compr Canc Netw 21:246","journal-title":"J Natl Compr Canc Netw"},{"key":"7602_CR16","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s10549-011-1872-9","volume":"131","author":"LC Collins","year":"2012","unstructured":"Collins LC, Marotti JD, Gelber S et al (2012) Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer. Breast Cancer Res Treat 131:1061\u20131066","journal-title":"Breast Cancer Res Treat"},{"key":"7602_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2021.153507","volume":"224","author":"X Jiang","year":"2021","unstructured":"Jiang X, Hu X, Gu Y et al (2021) Homologous recombination repair gene mutations in Chinese localized and locally advanced prostate cancer patients. Pathol Res Pract 224:153507","journal-title":"Pathol Res Pract"},{"key":"7602_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","volume":"19","author":"MM Li","year":"2017","unstructured":"Li MM, Datto M, Duncavage EJ et al (2017) Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the association for molecular pathology, american society of clinical oncology, and college of american pathologists. J Mol Diagn 19:4\u201323","journal-title":"J Mol Diagn"},{"key":"7602_CR19","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med 17:405\u2013424","journal-title":"Genet Med"},{"key":"7602_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-015-0504-3","volume":"13","author":"HA Azim","year":"2015","unstructured":"Azim HA, Nguyen B, Broh\u00e9e S, Zoppoli G, Sotiriou C (2015) Genomic aberrations in young and elderly breast cancer patients. BMC Med 13:1","journal-title":"BMC Med"},{"key":"7602_CR21","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1007\/s12325-015-0268-3","volume":"32","author":"SM Swain","year":"2015","unstructured":"Swain SM, Nunes R, Yoshizawa C, Rothney M, Sing AP (2015) Quantitative gene expression by recurrence score in ER-positive breast cancer, by age. Adv Ther 32:1222\u20131236","journal-title":"Adv Ther"},{"key":"7602_CR22","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10549-023-07074-z","volume":"202","author":"AD Isiklar","year":"2023","unstructured":"Isiklar AD, Aliyeva L, Yesilyurt A, Soyder A, Basaran G (2023) Frequency of germline pathogenic variants in breast cancer predisposition genes among young Turkish breast cancer patients. Breast Cancer Res Treat 202:297\u2013304","journal-title":"Breast Cancer Res Treat"},{"key":"7602_CR23","doi-asserted-by":"publisher","first-page":"674094","DOI":"10.3389\/fgene.2021.674094","volume":"12","author":"Y Su","year":"2021","unstructured":"Su Y, Yao Q, Xu Y et al (2021) Characteristics of germline non-BRCA mutation status of high-risk breast cancer patients in China and correlation with high-risk factors and multigene testing suggestions. Front Genet 12:674094","journal-title":"Front Genet"},{"key":"7602_CR24","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12885-022-09181-4","volume":"22","author":"O ElBiad","year":"2022","unstructured":"ElBiad O, Laraqui A, El Boukhrissi F et al (2022) Prevalence of specific and recurrent\/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North Africa. BMC Cancer 22:208","journal-title":"BMC Cancer"},{"key":"7602_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41523-021-00317-6","volume":"7","author":"JS Herzog","year":"2021","unstructured":"Herzog JS, Chavarri-Guerra Y, Castillo D et al (2021) Genetic epidemiology of BRCA1- and BRCA2-associated cancer across Latin America. NPJ Breast Cancer 7:107","journal-title":"NPJ Breast Cancer"},{"key":"7602_CR26","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/ijc.11271","volume":"106","author":"S de Sanjose","year":"2003","unstructured":"de Sanjose S, Leone M, Berez V et al (2003) Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: a population-based study. Int J Cancer 106:588\u2013593","journal-title":"Int J Cancer"},{"key":"7602_CR27","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1186\/s12885-020-07352-9","volume":"20","author":"J Bakkach","year":"2020","unstructured":"Bakkach J, Mansouri M, Derkaoui T et al (2020) Contribution of BRCA1 and BRCA2 germline mutations to early onset breast cancer: a series from north of Morocco. BMC Cancer 20:859","journal-title":"BMC Cancer"},{"key":"7602_CR28","doi-asserted-by":"publisher","first-page":"938561","DOI":"10.3389\/fonc.2022.938561","volume":"12","author":"NC van der Merwe","year":"2022","unstructured":"van der Merwe NC, Ntaita KS, Stofberg H, Combrink HM, Oosthuizen J, Kotze MJ (2022) Implementation of multigene panel testing for breast and ovarian cancer in South Africa: a step towards excellence in oncology for the public sector. Front Oncol 12:938561","journal-title":"Front Oncol"},{"key":"7602_CR29","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10549-006-9303-z","volume":"102","author":"KD Awadelkarim","year":"2007","unstructured":"Awadelkarim KD, Aceto G, Veschi S et al (2007) BRCA1 and BRCA2 status in a Central Sudanese series of breast cancer patients: interactions with genetic, ethnic and reproductive factors. Breast Cancer Res Treat 102:189\u2013199","journal-title":"Breast Cancer Res Treat"},{"key":"7602_CR30","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1158\/1078-0432.CCR-21-2572","volume":"28","author":"AG Waks","year":"2022","unstructured":"Waks AG, Kim D, Jain E et al (2022) Somatic and germline genomic alterations in very young women with breast cancer. Clin Cancer Res 28:2339\u20132348","journal-title":"Clin Cancer Res"},{"key":"7602_CR31","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1002\/cncr.24200","volume":"115","author":"MJ Hall","year":"2009","unstructured":"Hall MJ, Reid JE, Burbidge LA et al (2009) BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer 115:2222\u20132233","journal-title":"Cancer"},{"key":"7602_CR32","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1056\/NEJMoa2005936","volume":"384","author":"C Hu","year":"2021","unstructured":"Hu C, Hart SN, Gnanaolivu R et al (2021) A population-based study of genes previously implicated in breast cancer. N Engl J Med 384:440\u2013451","journal-title":"N Engl J Med"},{"key":"7602_CR33","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1056\/NEJMoa1913948","volume":"384","author":"L Dorling","year":"2021","unstructured":"Dorling L, Carvalho S, Allen J et al (2021) Breast cancer risk genes\u2014association analysis in more than 113,000 women. N Engl J Med 384:428\u2013439","journal-title":"N Engl J Med"},{"key":"7602_CR34","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/jnci\/djq055","volume":"102","author":"JL Bernstein","year":"2010","unstructured":"Bernstein JL, Haile RW, Stovall M et al (2010) Radiation exposure, the ATM Gene, and contralateral breast cancer in the women\u2019s environmental cancer and radiation epidemiology study. J Natl Cancer Inst 102:475\u2013483","journal-title":"J Natl Cancer Inst"},{"key":"7602_CR35","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.annonc.2023.01.009","volume":"34","author":"SJ Luen","year":"2023","unstructured":"Luen SJ, Viale G, Nik-Zainal S et al (2023) Genomic characterisation of hormone receptor-positive breast cancer arising in very young women. Ann Oncol 34:397\u2013409","journal-title":"Ann Oncol"},{"key":"7602_CR36","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1804710","volume":"379","author":"JA Sparano","year":"2018","unstructured":"Sparano JA, Gray RJ, Makower DF et al (2018) Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer. N Engl J Med 379:111\u2013121","journal-title":"N Engl J Med"},{"key":"7602_CR37","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.trecan.2020.01.007","volume":"6","author":"A Shahbandi","year":"2020","unstructured":"Shahbandi A, Nguyen HD, Jackson JG (2020) TP53 mutations and outcomes in breast cancer: reading beyond the headlines. Trends Cancer 6:98\u2013110","journal-title":"Trends Cancer"},{"key":"7602_CR38","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s10549-022-06509-3","volume":"192","author":"NC Pollock","year":"2022","unstructured":"Pollock NC, Ramroop JR, Hampel H et al (2022) Differences in somatic TP53 mutation type in breast tumors by race and receptor status. Breast Cancer Res Treat 192:639\u2013648","journal-title":"Breast Cancer Res Treat"},{"key":"7602_CR39","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.cell.2017.08.028","volume":"170","author":"ER Kastenhuber","year":"2017","unstructured":"Kastenhuber ER, Lowe SW (2017) Putting p53 in context. Cell 170:1062\u20131078","journal-title":"Cell"},{"key":"7602_CR40","doi-asserted-by":"publisher","first-page":"188556","DOI":"10.1016\/j.bbcan.2021.188556","volume":"1876","author":"LJ Hernandez Borrero","year":"2021","unstructured":"Hernandez Borrero LJ, El-Deiry WS (2021) Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting. Biochim Biophys Acta Rev Cancer 1876:188556","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"7602_CR41","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4048\/jbc.2015.18.1.16","volume":"18","author":"T Kim","year":"2015","unstructured":"Kim T, Han W, Kim MK et al (2015) Predictive significance of p53, Ki-67, and Bcl-2 expression for pathologic complete response after neoadjuvant chemotherapy for triple-negative breast cancer. J Breast Cancer 18:16\u201321","journal-title":"J Breast Cancer"},{"key":"7602_CR42","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/ijc.29715","volume":"138","author":"Y Wang","year":"2016","unstructured":"Wang Y, Xu Y, Chen J et al (2016) TP53 mutations are associated with higher rates of pathologic complete response to anthracycline\/cyclophosphamide-based neoadjuvant chemotherapy in operable primary breast cancer. Int J Cancer 138:489\u2013496","journal-title":"Int J Cancer"},{"key":"7602_CR43","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s10549-011-1412-7","volume":"132","author":"S Gluck","year":"2012","unstructured":"Gluck S, Ross JS, Royce M et al (2012) TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine +\/- trastuzumab. Breast Cancer Res Treat 132:781\u2013791","journal-title":"Breast Cancer Res Treat"},{"key":"7602_CR44","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1038\/s41467-018-04129-4","volume":"9","author":"Z Kan","year":"2018","unstructured":"Kan Z, Ding Y, Kim J et al (2018) Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures. Nat Commun 9:1725","journal-title":"Nat Commun"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-024-07602-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-024-07602-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-024-07602-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T23:35:33Z","timestamp":1743550533000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-024-07602-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,5]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["7602"],"URL":"https:\/\/doi.org\/10.1007\/s10549-024-07602-5","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[2025,1,5]]},"assertion":[{"value":"19 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Research Ethics Committee of Fujian Medical University Union Hospital (2020KJT031).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}